Safety, Tolerability, and Pharmacodynamics of IONIS-DGAT2Rx in Adult Patients With Type 2 Diabetes

NCT03334214 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Steatosis

Interventions

DRUG: IONIS DGAT2Rx
DRUG: Placebo

Sponsor

Ionis Pharmaceuticals, Inc.